Cargando…
Impact of a Plasmodium falciparum AMA1 Vaccine on Antibody Responses in Adult Malians
BACKGROUND: Apical Membrane Antigen 1 (AMA1) of Plasmodium falciparum merozoites is a leading blood-stage malaria vaccine candidate. Protection of Aotus monkeys after vaccination with AMA1 correlates with antibody responses. STUDY DESIGN/RESULTS: A randomized, controlled, double-blind phase 1 clinic...
Autores principales: | Dicko, Alassane, Diemert, David J., Sagara, Issaka, Sogoba, Moussa, Niambele, Mohamed B., Assadou, Mahamadoun H., Guindo, Ousmane, Kamate, Beh, Baby, Mounirou, Sissoko, Mady, Malkin, Elissa M., Fay, Michael P., Thera, Mahamadou A., Miura, Kazutoyo, Dolo, Amagana, Diallo, Dapa A., Mullen, Gregory E., Long, Carole A., Saul, Allan, Doumbo, Ogobara, Miller, Louis H. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2013939/ https://www.ncbi.nlm.nih.gov/pubmed/17940609 http://dx.doi.org/10.1371/journal.pone.0001045 |
Ejemplares similares
-
Phase 1 Study of a Combination AMA1 Blood Stage Malaria Vaccine in Malian Children
por: Dicko, Alassane, et al.
Publicado: (2008) -
Safety and Immunogenicity of an AMA-1 Malaria Vaccine in Malian Adults: Results of a Phase 1 Randomized Controlled Trial
por: Thera, Mahamadou A., et al.
Publicado: (2008) -
Safety and Immunogenicity of an AMA1 Malaria Vaccine in Malian Children: Results of a Phase 1 Randomized Controlled Trial
por: Thera, Mahamadou A., et al.
Publicado: (2010) -
Non-Apical Membrane Antigen 1 (AMA1) IgGs from Malian Children Interfere with Functional Activity of AMA1 IgGs as Judged by Growth Inhibition Assay
por: Miura, Kazutoyo, et al.
Publicado: (2011) -
Phase 1 randomized controlled trial to evaluate the safety and immunogenicity of recombinant Pichia pastoris-expressed Plasmodium falciparum apical membrane antigen 1 (PfAMA1-FVO [25-545]) in healthy Malian adults in Bandiagara
por: Thera, Mahamadou A., et al.
Publicado: (2016)